Material deprivation and access to cancer care in a universal healthcare system
Davis LE, Coburn NG, Hallet J, Earle CC, Liu Y, Myrehaug S, Mahar AL. Cancer. 2020; 126(20):4545-52. Epub 2020 Aug 3.
Publications
The association between endocrine therapy use and dementia among post-menopausal women treated for early-stage breast cancer in Ontario, Canada
Blanchette PS, Lam M, Le B, Richard L, Shariff SZ, Pritchard KI, Raphael J, Vandenberg T, Fernandes R, Desautels D, Chan KKW, Earle CC. J Geriatr Oncol. 2020; 11(7):1132-7. Epub 2020 Jun 28.
Impact of standardized Edmonton Symptom Assessment System use on emergency department visits and hospitalization: results of a population-based retrospective matched cohort analysis
Barbera L, Sutradhar R, Seow H, Earle CC, Howell D, Mittmann N, Li Q, Thiruchelvam D. JCO Oncol Pract. 2020; 16(9):e958-65. Epub 2020 May 28.
Healthcare resource utilization in myeloproliferative neoplasms: a population-based study from Ontario, Canada
Bankar A, Zhao H, Iqbal J, Coxford R, Cheung MC, Mozessohn L, Earle CC, Gupta V. Leuk Lymphoma. 2020; 61(8):1908-19. Epub 2020 Apr 23.
Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada
Dai WF, Beca J, Croxford R, Isaranawatchai W, Menjak IB, Petrella TM, Mittmann N, Earle CC, Gavura S, Hanna TP, Chan KKW. BMC Cancer. 2020; 20(1):304. Epub 2020 Apr 15.
Development and validation of a prognostic survival model with patient-reported outcomes for patients with cancer
Seow H, Tanuseputro P, Barbera L, Earle C, Guthrie D, Isenberg S, Juergens R, Myers J, Brouwers M, Sutradhar R. JAMA Netw Open. 2020; 3(4):e201768. Epub 2020 Apr 1.
Assessing the impact of early identification of patients appropriate for palliative care on resource use and costs in the final month of life
Long Hong NJ, Liu N, Wright FC, MacKinnon M, Seung SJ, Earle CC, Gradin S, Sati S, Buchman S, Mittmann N. JCO Oncol Pract. 2020; 16(8):e688-702. Epub 2020 Mar 20.
Health system costs for cancer medications and radiation treatment in Ontario for the 4 most common cancers: a retrospective cohort study
Mittmann N, Liu N, Cheng SY, Seung SJ, Saxena FE, Hong NJL, Earle CC, Cheung M, Leighl NB, Coburn NG, DeAngelis C, Evans WK. CMAJ Open. 2020; 8(1):E191-8. Epub 2020 Mar 16.
Benefits of high-volume medical oncology care for noncurable pancreatic adenocarcinoma: a population-based analysis
Hallet J, Davis L, Mahar A, Mavros M, Beyfuss K, Liu Y, Law CHL, Earle C, Coburn N. J Natl Compr Canc Netw. 2020; 18(3):297-303. Epub 2020 Mar 1.
Healthcare utilization in patients with higher-risk MDS/low-blast count AML treated with azacitidine in the ‘real-world’
Mozessohn L, Cheung MC, Mittmann N, Earle CC, Liu N, Buckstein R. Leuk Lymphoma. 2020; 61(6):1445-54. Epub 2020 Feb 8.